Subscribe

Category: AAD Summer 2025 Conference Coverage

Jennifer Hsiao, MD: Dual Biologic Management in Hidradenitis Suppurativa
Dr. Jennifer Hsiao explores dual biologic therapy as a potential strategy for managing complex, treatment-resistant cases of hidradenitis suppurativa.
PLAY
Neal Bhatia, MD: Topical Therapies Pipeline
Dr. Neal Bhatia reviews promising topical therapies in development, highlighting new mechanisms and formulations shaping the future of dermatologic care.
PLAY
Julie Harper, MD: What’s New in Rosacea
Dr. Harper discusses results from head-to-head studies comparing new and existing oral rosacea treatments and navigating the difficulties of treating neurogenic rosacea.
PLAY
Clive Maopang Liu, MD: Update on Topical Therapy for Psoriasis
Dr. Liu discusses new and emerging topical therapies for psoriasis and the continued value of topical therapies in psoriasis treatment.
PLAY
Andrea Tesvich Murina, MD: Advancements in Oral Therapies for Psoriasis
Dr. Andrea Murina discusses how oral therapies can serve as an effective entry point to systemic treatment for patients with psoriasis.
PLAY
Mark Lebwohl, MD: Special Factors to Consider in Elderly Patients with Psoriasis
Dr. Mark Lebwohl outlines key considerations for treating psoriasis in elderly patients, including comorbidities, cancer risk, and treatment affordability.
PLAY
Steven Daniel Daveluy, MD, FAAD: AI Phenotyping of Hidradenitis Suppurativa
Dr. Daveluy discusses an exciting new project to uncover insights into HS disease patterns through analysis with artificial intelligence.
PLAY
Nada Elbuluk, MD: Skin of Color Primer—Inflammatory Diseases
Dr. Elbuluk discusses unique considerations pertaining to inflammatory skin diseases in patients with skin of color.
PLAY
Saakshi Khattri, MD: Psoriatic Arthritis Update
Dr. Khattri discusses emerging psoriatic arthritis treatments on the horizon, including deucravacitinib, zasocitinib, and icotrokinra.
PLAY
James Song, MD, FAAD: Utility of IL-17 Inhibitors for Psoriatic Disease
Dr. James Song reviews how IL-17 inhibitors can be especially effective in treating psoriatic arthritis, special-site psoriasis, and biologic-experienced patients.
PLAY
Jeffrey Cohen, MD, MPH: Treatment of Psoriasis in High-impact Sites
Dr. Cohen discusses the unique challenges of managing Psoriasis in high-impact anatomical sites, where symptoms can significantly affect daily function, comfort, and quality of life
PLAY
Ashish Bhatia, MD: New Technologies in Dermatology
Dr. Bhatia highlights emerging technologies that are shaping the future of dermatologic care, showcasing innovations in skin imaging, regenerative medicine, and personalized therapies. His presentation
PLAY

More JCAD.TV: